Fs(2)Ketc02473, PenD14 has increased mortality during development | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/PenNLSB-.UASp
Fs(2)Ketc02473, PenD14 has increased mortality during development | maternal effect phenotype, enhanceable by PenSNLSB-.UASp/Scer\GAL4VP16.nanos.UTR
Fs(2)Ketc02473 has increased mortality during development | maternal effect phenotype, non-enhanceable by PenD14
Fs(2)Ketc02473, PenD14 has increased mortality during development | maternal effect phenotype, non-enhanceable by Scer\GAL4VP16.nanos.UTR/PenCASB-.UASp
Fs(2)Ketc02473, PenD14 has increased mortality during development | maternal effect phenotype, non-enhanceable by Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp
Fs(2)Ketc02473 has increased mortality during development | maternal effect phenotype, non-suppressible by PenD14
Fs(2)Ketc02473, PenD14 has increased mortality during development | maternal effect phenotype, non-suppressible by Scer\GAL4VP16.nanos.UTR/PenCASB-.UASp
Fs(2)Ketc02473, PenD14 has increased mortality during development | maternal effect phenotype, non-suppressible by Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp
Fs(2)Ketc02473 is a non-enhancer of increased mortality during development | maternal effect phenotype of PenD14
Fs(2)Ketc02473 is a non-suppressor of increased mortality during development | maternal effect phenotype of PenD14
Fs(2)Ketc02473, PenD14, PenNLSB-.UASp, Scer\GAL4VP16.nanos.UTR has mitotic spindle | maternal effect | embryonic stage phenotype
Fs(2)Ketc02473, PenD14, PenNLSB-.UASp, Scer\GAL4VP16.nanos.UTR has aster | maternal effect | embryonic stage phenotype
Fs(2)Ketc02473, PenD14, PenNLSB-.UASp, Scer\GAL4VP16.nanos.UTR has nuclear envelope | maternal effect | embryonic stage phenotype